Medicamen Biotech Limited

NSE:MEDICAMEQ India Drug Manufacturers - Specialty & Generic
Market Cap
$43.10 Million
₹3.73 Billion INR
Market Cap Rank
#26369 Global
#1410 in India
Share Price
₹275.20
Change (1 day)
-2.76%
52-Week Range
₹275.20 - ₹523.00
All Time High
₹1195.88
About

Medicamen Biotech Limited, a pharmaceutical company, research, develops, manufactures, markets, sells, and distributes pharmaceutical formulations in India and internationally. The company offers drugs in various forms, including tablet, capsule, syrups, oral solution, and drops. Its products are used in therapeutic areas comprising cancer care, cardiology, CNS, diabetology, anti-infective, anti-… Read more

Medicamen Biotech Limited (MEDICAMEQ) - Total Liabilities

Latest total liabilities as of September 2025: ₹916.99 Million INR

Based on the latest financial reports, Medicamen Biotech Limited (MEDICAMEQ) has total liabilities worth ₹916.99 Million INR as of September 2025.

Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Medicamen Biotech Limited - Total Liabilities Trend (2006–2025)

This chart illustrates how Medicamen Biotech Limited's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.

Medicamen Biotech Limited Competitors by Total Liabilities

The table below lists competitors of Medicamen Biotech Limited ranked by their total liabilities.

Company Country Total Liabilities
WiseChip Semiconductor
TWO:5245
Taiwan NT$990.75 Million
HCT Co. Ltd
KQ:072990
Korea ₩82.24 Billion
Pacific Online Limited
PINK:PCOLF
USA $229.88 Million
Daesung Eltec Co. Ltd
KQ:025440
Korea ₩292.76 Billion
Enzo Biochem Inc
NYSE:ENZ
USA $20.12 Million
PT TBS Energi Utama Tbk
F:6AU
Germany €563.55 Million
TRF Limited
NSE:TRF
India ₹2.57 Billion

Liability Composition Analysis (2006–2025)

This chart breaks down Medicamen Biotech Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 2.61 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.33 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.25 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Medicamen Biotech Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Medicamen Biotech Limited (2006–2025)

The table below shows the annual total liabilities of Medicamen Biotech Limited from 2006 to 2025.

Year Total Liabilities Change
2025-03-31 ₹841.04 Million -3.95%
2024-03-31 ₹875.67 Million +2.89%
2023-03-31 ₹851.03 Million +7.42%
2022-03-31 ₹792.24 Million +29.63%
2021-03-31 ₹611.18 Million +1.75%
2020-03-31 ₹600.66 Million +20.23%
2019-03-31 ₹499.59 Million +16.34%
2018-03-31 ₹429.43 Million -7.89%
2017-03-31 ₹466.20 Million +10.71%
2016-03-31 ₹421.09 Million -18.20%
2015-03-31 ₹514.78 Million +7.15%
2014-03-31 ₹480.41 Million -2.98%
2013-03-31 ₹495.17 Million +1.46%
2012-03-31 ₹488.06 Million -1.61%
2011-03-31 ₹496.06 Million +19.76%
2010-03-31 ₹414.22 Million +26.09%
2009-03-31 ₹328.50 Million -18.26%
2008-03-31 ₹401.88 Million +10.58%
2007-03-31 ₹363.44 Million +43.93%
2006-03-31 ₹252.51 Million --